<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/672"/><api:result><api:object category="publication" id="672" last-affected-when="2024-03-14T05:39:12.547+00:00" last-modified-when="2024-03-14T05:39:12.547+00:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/672" created-when="2010-05-17T13:46:25.247+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>false</api:ever-approved><api:reporting-date-1>1999-01-01</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="1908174" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.7164/antibiotics.52.862" last-modified-when="2022-09-12T02:20:17.877+01:00"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>WRIGLEY</api:last-name><api:initials>SK</api:initials><api:first-names>STEPHEN K</api:first-names><api:separate-first-names><api:first-name>STEPHEN</api:first-name><api:first-name>K</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>SADEGHI</api:last-name><api:initials>R</api:initials><api:first-names>ROYA</api:first-names><api:separate-first-names><api:first-name>ROYA</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>BAHL</api:last-name><api:initials>S</api:initials><api:first-names>SANGEETA</api:first-names><api:separate-first-names><api:first-name>SANGEETA</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>WHITING</api:last-name><api:initials>AJ</api:initials><api:first-names>ANDREW J</api:first-names><api:separate-first-names><api:first-name>ANDREW</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>AINSWORTH</api:last-name><api:initials>AM</api:initials><api:first-names>A MARTYN</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>MARTYN</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>MARTIN</api:last-name><api:initials>SM</api:initials><api:first-names>STEVEN M</api:first-names><api:separate-first-names><api:first-name>STEVEN</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>KATZER</api:last-name><api:initials>W</api:initials><api:first-names>WERNER</api:first-names><api:separate-first-names><api:first-name>WERNER</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>FORD</api:last-name><api:initials>R</api:initials><api:first-names>ROBERT</api:first-names><api:separate-first-names><api:first-name>ROBERT</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>KAU</api:last-name><api:initials>DA</api:initials><api:first-names>DAVID A</api:first-names><api:separate-first-names><api:first-name>DAVID</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>ROBINSON</api:last-name><api:initials>N</api:initials><api:first-names>NEIL</api:first-names><api:separate-first-names><api:first-name>NEIL</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>HAYES</api:last-name><api:initials>MA</api:initials><api:first-names>MARTIN A</api:first-names><api:separate-first-names><api:first-name>MARTIN</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>ELCOCK</api:last-name><api:initials>C</api:initials><api:first-names>CLAIRE</api:first-names><api:separate-first-names><api:first-name>CLAIRE</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>MANDER</api:last-name><api:initials>T</api:initials><api:first-names>THOMAS</api:first-names><api:separate-first-names><api:first-name>THOMAS</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>MOORES</api:last-name><api:initials>M</api:initials><api:first-names>MICHAEL</api:first-names><api:separate-first-names><api:first-name>MICHAEL</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.7164/antibiotics.52.862</api:text><api:links><api:link type="doi" href="http://doi.org/10.7164/antibiotics.52.862"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.7164/antibiotics.52.862"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1881-1469</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965812"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0021-8820</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965812"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>10</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>The Journal of Antibiotics</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>en</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>862</api:begin-page><api:end-page>872</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Japan Antibiotics Research Association</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.7164/antibiotics.52.862</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>29</api:day><api:month>2</api:month><api:year>2012</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>A Novel (6S)-4,6-Dimethyldodeca-2E,4E-dienoyl Ester of Phomalactone and Related .ALPHA.-Pyrone Esters from a Phomopsis sp. with Cytokine Production Inhibitory Activity.</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>52</api:text></api:field></api:native></api:record><api:record format="native" id="94419" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0032759228" last-modified-when="2022-05-24T22:16:32.023+01:00"><api:citation-count>11</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>A series of novel 6-substituted 5,6-dihydro-5-hydroxy-α-pyrone esters, 1 ~ 3, isolated from fermentations of a Phomopsis sp. (Xenova culture collection no. X22502) have been identified as inhibitors of lipopolysaccharide (LPS)-induced cytokine production. These include the (6S)-4,6-dimethyldodecadien-2E,4E-dienoyl ester of phomalactone, 1, and two analogues bearing a prop-2E-enoic acid moiety at the 6-position of the α-pyrone ring. (6S)-4,6-Dimethyl-2E,4E-dienoic acid 4, and a hydroxylated analogue, 5, were also isolated and characterised. The most potent cytokine production inhibitor was 1, which inhibited LPS-induced tumour necrosis factor α (TNFα) production by U937 cells and LPS-induced interleukin 1β (IL-1β) production by peripheral blood mononuclear cells (PBMC) with IC50 values of 80 nM and 190 nM respectively. The effect of 1 in PBMC was selective for IL-1β relative to TNFα. The inhibition of IL-1β production by 1 involved a post-translational mechanism of action at the level of IL-1β secretion as demonstrated by the lack of an effect on cell-associated IL-1β production. 1 showed no effect on the activity of caspase 1 in cytosolic extracts from the THP1 monocytic cell line.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Wrigley</api:last-name><api:initials>SK</api:initials><api:first-names>SK</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>K</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">TerraGen Discovery (UK) Ltd.</api:line><api:line type="city">Slough</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7004143549</api:identifier></api:identifiers></api:person><api:person><api:last-name>Sadeghi</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">TerraGen Discovery (UK) Ltd.</api:line><api:line type="city">Slough</api:line><api:line type="country">United Kingdom</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Pfizer Limited, UK</api:line><api:line type="city">Tadworth</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">17036452000</api:identifier></api:identifiers></api:person><api:person><api:last-name>Bahl</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Cantab Pharmaceuticals Ltd.</api:line><api:line type="city">Hamilton</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7006981924</api:identifier></api:identifiers></api:person><api:person><api:last-name>Whiting</api:last-name><api:initials>AJ</api:initials><api:first-names>AJ</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">TerraGen Discovery (UK) Ltd.</api:line><api:line type="city">Slough</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7005545115</api:identifier></api:identifiers></api:person><api:person><api:last-name>Ainsworth</api:last-name><api:initials>AM</api:initials><api:first-names>AM</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">TerraGen Discovery (UK) Ltd.</api:line><api:line type="city">Slough</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">35798080300</api:identifier></api:identifiers></api:person><api:person><api:last-name>Martin</api:last-name><api:initials>SM</api:initials><api:first-names>SM</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">TerraGen Discovery (UK) Ltd.</api:line><api:line type="city">Slough</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">57207412717</api:identifier></api:identifiers></api:person><api:person><api:last-name>Katzer</api:last-name><api:initials>W</api:initials><api:first-names>W</api:first-names><api:separate-first-names><api:first-name>W</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">TerraGen Discovery (UK) Ltd.</api:line><api:line type="city">Slough</api:line><api:line type="country">United Kingdom</api:line></api:address><api:address iso-country-code="DE"><api:line type="organisation">Biotechon</api:line><api:line type="city">Berlin</api:line><api:line type="country">Germany</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6506290058</api:identifier></api:identifiers></api:person><api:person><api:last-name>Ford</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">TerraGen Discovery (UK) Ltd.</api:line><api:line type="city">Slough</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">57198130390</api:identifier></api:identifiers></api:person><api:person><api:last-name>Kau</api:last-name><api:initials>DA</api:initials><api:first-names>DA</api:first-names><api:separate-first-names><api:first-name>D</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">TerraGen Discovery (UK) Ltd.</api:line><api:line type="city">Slough</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6602155481</api:identifier></api:identifiers></api:person><api:person><api:last-name>Robinson</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Cantab Pharmaceuticals Ltd.</api:line><api:line type="city">Hamilton</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">57220720817</api:identifier></api:identifiers></api:person><api:person><api:last-name>Hayes</api:last-name><api:initials>MA</api:initials><api:first-names>MA</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">TerraGen Discovery (UK) Ltd.</api:line><api:line type="city">Slough</api:line><api:line type="country">United Kingdom</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">GlaxoSmithKline plc.</api:line><api:line type="city">Brentford</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">22953360700</api:identifier></api:identifiers></api:person><api:person><api:last-name>Elcock</api:last-name><api:initials>C</api:initials><api:first-names>C</api:first-names><api:separate-first-names><api:first-name>C</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">TerraGen Discovery (UK) Ltd.</api:line><api:line type="city">Slough</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">57455654300</api:identifier></api:identifiers></api:person><api:person><api:last-name>Mander</api:last-name><api:initials>T</api:initials><api:first-names>T</api:first-names><api:separate-first-names><api:first-name>T</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">TerraGen Discovery (UK) Ltd.</api:line><api:line type="city">Slough</api:line><api:line type="country">United Kingdom</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">GlaxoSmithKline plc.</api:line><api:line type="city">Brentford</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6701681878</api:identifier></api:identifiers></api:person><api:person><api:last-name>Moore</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Cantab Pharmaceuticals Ltd.</api:line><api:line type="city">Hamilton</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7404471672</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.7164/antibiotics.52.862</api:text><api:links><api:link type="doi" href="http://doi.org/10.7164/antibiotics.52.862"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.7164/antibiotics.52.862"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10604755</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0021-8820</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965812"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>10</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Journal of Antibiotics</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>862</api:begin-page><api:end-page>872</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>1</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>A novel (6S)-4,6-dimethyldodeca-2E,4E-dienoyl ester of phomalactone and related α-pyrone esters from a Phomopsis sp. with cytokine production inhibitory activity</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>52</api:text></api:field></api:native></api:record><api:record format="native" id="672" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10604755" last-modified-when="2022-04-26T23:20:18.263+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>A series of novel 6-substituted 5,6-dihydro-5-hydroxy-alpha-pyrone esters, 1 approximately 3, isolated from fermentations of a Phomopsis sp. (Xenova culture collection no. X22502) have been identified as inhibitors of lipopolysaccharide (LPS)-induced cytokine production. These include the (6S)-4,6-dimethyldodecadien-2E,4E-dienoyl ester of phomalactone, 1, and two analogues bearing a prop-2E-enoic acid moiety at the 6-position of the alpha-pyrone ring. (6S)-4,6-Dimethyl-2E,4E-dienoic acid, 4, and a hydroxylated analogue, 5, were also isolated and characterised. The most potent cytokine production inhibitor was 1, which inhibited LPS-induced tumour necrosis factor alpha (TNFalpha) production by U937 cells and LPS-induced interleukin 1beta (IL-1beta) production by peripheral blood mononuclear cells (PBMC) with IC50 values of 80 nM and 190 nM respectively. The effect of 1 in PBMC was selective for IL-1beta relative to TNFalpha. The inhibition of IL-1beta production by 1 involved a post-translational mechanism of action at the level of IL-1beta secretion as demonstrated by the lack of an effect on cell-associated IL-1beta production. 1 showed no effect on the activity of caspase 1 in cytosolic extracts from the THP1 monocytic cell line.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Wrigley</api:last-name><api:initials>SK</api:initials><api:first-names>SK</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>K</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">TerraGen Discovery, UK.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Sadeghi</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Bahl</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Whiting</api:last-name><api:initials>AJ</api:initials><api:first-names>AJ</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Ainsworth</api:last-name><api:initials>AM</api:initials><api:first-names>AM</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Martin</api:last-name><api:initials>SM</api:initials><api:first-names>SM</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Katzer</api:last-name><api:initials>W</api:initials><api:first-names>W</api:first-names><api:separate-first-names><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Ford</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kau</api:last-name><api:initials>DA</api:initials><api:first-names>DA</api:first-names><api:separate-first-names><api:first-name>D</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Robinson</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Hayes</api:last-name><api:initials>MA</api:initials><api:first-names>MA</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Elcock</api:last-name><api:initials>C</api:initials><api:first-names>C</api:first-names><api:separate-first-names><api:first-name>C</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Mander</api:last-name><api:initials>T</api:initials><api:first-names>T</api:first-names><api:separate-first-names><api:first-name>T</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Moore</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10604755</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.7164/antibiotics.52.862</api:text><api:links><api:link type="doi" href="http://doi.org/10.7164/antibiotics.52.862"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.7164/antibiotics.52.862"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0021-8820</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965812"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>10</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>J Antibiot (Tokyo)</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Dose-Response Relationship, Drug</api:keyword><api:keyword scheme="mesh">Esters</api:keyword><api:keyword scheme="mesh">Fermentation</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Interleukin-1</api:keyword><api:keyword scheme="mesh">Lactones</api:keyword><api:keyword scheme="mesh">Lipopolysaccharides</api:keyword><api:keyword scheme="mesh">Molecular Structure</api:keyword><api:keyword scheme="mesh">Pyrones</api:keyword><api:keyword scheme="mesh">Structure-Activity Relationship</api:keyword><api:keyword scheme="mesh">Tumor Necrosis Factor-alpha</api:keyword><api:keyword scheme="mesh">U937 Cells</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>England</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>862</api:begin-page><api:end-page>872</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>10</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>13</api:day><api:month>1</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>A novel (6S)-4,6-dimethyldodeca-2E,4E-dienoyl ester of phomalactone and related alpha-pyrone esters from a Phomopsis sp. with cytokine production inhibitory activity.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Comparative Study</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>52</api:text></api:field></api:native></api:record><api:record format="native" id="881980" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10604755" last-modified-when="2020-07-21T17:27:29.317+01:00"><api:citation-count>1</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>A series of novel 6-substituted 5,6-dihydro-5-hydroxy-alpha-pyrone esters, 1 approximately 3, isolated from fermentations of a Phomopsis sp. (Xenova culture collection no. X22502) have been identified as inhibitors of lipopolysaccharide (LPS)-induced cytokine production. These include the (6S)-4,6-dimethyldodecadien-2E,4E-dienoyl ester of phomalactone, 1, and two analogues bearing a prop-2E-enoic acid moiety at the 6-position of the alpha-pyrone ring. (6S)-4,6-Dimethyl-2E,4E-dienoic acid, 4, and a hydroxylated analogue, 5, were also isolated and characterised. The most potent cytokine production inhibitor was 1, which inhibited LPS-induced tumour necrosis factor alpha (TNFalpha) production by U937 cells and LPS-induced interleukin 1beta (IL-1beta) production by peripheral blood mononuclear cells (PBMC) with IC50 values of 80 nM and 190 nM respectively. The effect of 1 in PBMC was selective for IL-1beta relative to TNFalpha. The inhibition of IL-1beta production by 1 involved a post-translational mechanism of action at the level of IL-1beta secretion as demonstrated by the lack of an effect on cell-associated IL-1beta production. 1 showed no effect on the activity of caspase 1 in cytosolic extracts from the THP1 monocytic cell line.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">TerraGen Discovery, UK.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Wrigley</api:last-name><api:initials>SK</api:initials><api:first-names>SK</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>K</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Sadeghi</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Bahl</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Whiting</api:last-name><api:initials>AJ</api:initials><api:first-names>AJ</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Ainsworth</api:last-name><api:initials>AM</api:initials><api:first-names>AM</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Martin</api:last-name><api:initials>SM</api:initials><api:first-names>SM</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Katzer</api:last-name><api:initials>W</api:initials><api:first-names>W</api:first-names><api:separate-first-names><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Ford</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kau</api:last-name><api:initials>DA</api:initials><api:first-names>DA</api:first-names><api:separate-first-names><api:first-name>D</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Robinson</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Hayes</api:last-name><api:initials>MA</api:initials><api:first-names>MA</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Elcock</api:last-name><api:initials>C</api:initials><api:first-names>C</api:first-names><api:separate-first-names><api:first-name>C</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Mander</api:last-name><api:initials>T</api:initials><api:first-names>T</api:first-names><api:separate-first-names><api:first-name>T</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Moore</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.7164/antibiotics.52.862</api:text><api:links><api:link type="doi" href="http://doi.org/10.7164/antibiotics.52.862"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.7164/antibiotics.52.862"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1881-1469</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965812"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10604755</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0021-8820</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965812"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>10</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>The Journal of antibiotics</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">U937 Cells</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Esters</api:keyword><api:keyword scheme="mesh">Lactones</api:keyword><api:keyword scheme="mesh">Pyrones</api:keyword><api:keyword scheme="mesh">Lipopolysaccharides</api:keyword><api:keyword scheme="mesh">Tumor Necrosis Factor-alpha</api:keyword><api:keyword scheme="mesh">Interleukin-1</api:keyword><api:keyword scheme="mesh">Fermentation</api:keyword><api:keyword scheme="mesh">Molecular Structure</api:keyword><api:keyword scheme="mesh">Structure-Activity Relationship</api:keyword><api:keyword scheme="mesh">Dose-Response Relationship, Drug</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>862</api:begin-page><api:end-page>872</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>10</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>22</api:day><api:month>12</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>A novel (6S)-4,6-dimethyldodeca-2E,4E-dienoyl ester of phomalactone and related alpha-pyrone esters from a Phomopsis sp. with cytokine production inhibitory activity.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Comparative Study</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>52</api:text></api:field></api:native></api:record><api:record format="native" id="2770684" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1073636056" last-modified-when="2023-11-25T23:26:49.543+00:00"><api:citation-count>10</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>WRIGLEY</api:last-name><api:initials>SK</api:initials><api:first-names>STEPHEN K</api:first-names><api:separate-first-names><api:first-name>STEPHEN</api:first-name><api:first-name>K</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">TerraGen Discovery (UK) Ltd</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0641746456.09</api:identifier></api:identifiers></api:person><api:person><api:last-name>SADEGHI</api:last-name><api:initials>R</api:initials><api:first-names>ROYA</api:first-names><api:separate-first-names><api:first-name>ROYA</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">TerraGen Discovery (UK) Ltd</api:line></api:address><api:address><api:line type="full">Present addresses: Pfizer Ltd</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01035414647.79</api:identifier></api:identifiers></api:person><api:person><api:last-name>BAHL</api:last-name><api:initials>S</api:initials><api:first-names>SANGEETA</api:first-names><api:separate-first-names><api:first-name>SANGEETA</api:first-name></api:separate-first-names><api:addresses><api:address><api:line type="full">Xenova Ltd</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0653053047.99</api:identifier></api:identifiers></api:person><api:person><api:last-name>WHITING</api:last-name><api:initials>AJ</api:initials><api:first-names>ANDREW J</api:first-names><api:separate-first-names><api:first-name>ANDREW</api:first-name><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">TerraGen Discovery (UK) Ltd</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0737065625.97</api:identifier></api:identifiers></api:person><api:person><api:last-name>AINSWORTH</api:last-name><api:initials>AM</api:initials><api:first-names>A MARTYN</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>MARTYN</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">TerraGen Discovery (UK) Ltd</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.014542335666.62</api:identifier></api:identifiers></api:person><api:person><api:last-name>MARTIN</api:last-name><api:initials>SM</api:initials><api:first-names>STEVEN M</api:first-names><api:separate-first-names><api:first-name>STEVEN</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">TerraGen Discovery (UK) Ltd</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.011221422552.02</api:identifier></api:identifiers></api:person><api:person><api:last-name>KATZER</api:last-name><api:initials>W</api:initials><api:first-names>WERNER</api:first-names><api:separate-first-names><api:first-name>WERNER</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">TerraGen Discovery (UK) Ltd</api:line></api:address><api:address><api:line type="full">Present addresses: Biotechon</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01206652056.36</api:identifier></api:identifiers></api:person><api:person><api:last-name>FORD</api:last-name><api:initials>R</api:initials><api:first-names>ROBERT</api:first-names><api:separate-first-names><api:first-name>ROBERT</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">TerraGen Discovery (UK) Ltd</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01340160250.78</api:identifier></api:identifiers></api:person><api:person><api:last-name>KAU</api:last-name><api:initials>DA</api:initials><api:first-names>DAVID A</api:first-names><api:separate-first-names><api:first-name>DAVID</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">TerraGen Discovery (UK) Ltd</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01270055430.88</api:identifier></api:identifiers></api:person><api:person><api:last-name>ROBINSON</api:last-name><api:initials>N</api:initials><api:first-names>NEIL</api:first-names><api:separate-first-names><api:first-name>NEIL</api:first-name></api:separate-first-names><api:addresses><api:address><api:line type="full">Xenova Ltd</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0666005621.42</api:identifier></api:identifiers></api:person><api:person><api:last-name>HAYES</api:last-name><api:initials>MA</api:initials><api:first-names>MARTIN A</api:first-names><api:separate-first-names><api:first-name>MARTIN</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">TerraGen Discovery (UK) Ltd</api:line></api:address><api:address><api:line type="full">Present addresses: Glaxo Wellcome</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.07601673655.58</api:identifier></api:identifiers></api:person><api:person><api:last-name>ELCOCK</api:last-name><api:initials>C</api:initials><api:first-names>CLAIRE</api:first-names><api:separate-first-names><api:first-name>CLAIRE</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">TerraGen Discovery (UK) Ltd</api:line></api:address></api:addresses></api:person><api:person><api:last-name>MANDER</api:last-name><api:initials>T</api:initials><api:first-names>THOMAS</api:first-names><api:separate-first-names><api:first-name>THOMAS</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">TerraGen Discovery (UK) Ltd</api:line></api:address><api:address><api:line type="full">Present addresses: Glaxo Wellcome</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01356106673.08</api:identifier></api:identifiers></api:person><api:person><api:last-name>MOORES</api:last-name><api:initials>M</api:initials><api:first-names>MICHAEL</api:first-names><api:separate-first-names><api:first-name>MICHAEL</api:first-name></api:separate-first-names><api:addresses><api:address><api:line type="full">Xenova Ltd</api:line></api:address></api:addresses></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.7164/antibiotics.52.862</api:text><api:links><api:link type="doi" href="http://doi.org/10.7164/antibiotics.52.862"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.7164/antibiotics.52.862"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10604755</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0021-8820</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965812"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>10</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>The Journal of Antibiotics</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">3101 Biochemistry and Cell Biology</api:keyword><api:keyword scheme="for-2020">31 Biological Sciences</api:keyword><api:keyword scheme="mesh">Dose-Response Relationship, Drug</api:keyword><api:keyword scheme="mesh">Esters</api:keyword><api:keyword scheme="mesh">Fermentation</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Interleukin-1</api:keyword><api:keyword scheme="mesh">Lactones</api:keyword><api:keyword scheme="mesh">Lipopolysaccharides</api:keyword><api:keyword scheme="mesh">Molecular Structure</api:keyword><api:keyword scheme="mesh">Pyrones</api:keyword><api:keyword scheme="mesh">Structure-Activity Relationship</api:keyword><api:keyword scheme="mesh">Tumor Necrosis Factor-alpha</api:keyword><api:keyword scheme="mesh">U937 Cells</api:keyword></api:keywords></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Bronze OA</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>862</api:begin-page><api:end-page>872</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>1999</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Japan Antibiotics Research Association</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>0.24</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>A Novel (6S)-496-Dimethyldodeca-2E, 4E-dienoyl Ester of Phomalactone and Related α-Pyrone Esters from a Phomopsis sp. with Cytokine Production Inhibitory Activity</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>52</api:text></api:field></api:native></api:record><api:record format="native" id="240799" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000083355400003" last-modified-when="2024-03-14T05:39:12.65+00:00"><api:citation-count>11</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Wrigley</api:last-name><api:initials>SK</api:initials><api:first-names>SK</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>K</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Sadeghi</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Bahl</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Whiting</api:last-name><api:initials>AJ</api:initials><api:first-names>AJ</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Ainsworth</api:last-name><api:initials>AM</api:initials><api:first-names>AM</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Martin</api:last-name><api:initials>SM</api:initials><api:first-names>SM</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Katzer</api:last-name><api:initials>W</api:initials><api:first-names>W</api:first-names><api:separate-first-names><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Ford</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kau</api:last-name><api:initials>DA</api:initials><api:first-names>DA</api:first-names><api:separate-first-names><api:first-name>D</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Robinson</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Hayes</api:last-name><api:initials>MA</api:initials><api:first-names>MA</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Elcock</api:last-name><api:initials>C</api:initials><api:first-names>C</api:first-names><api:separate-first-names><api:first-name>C</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Mander</api:last-name><api:initials>T</api:initials><api:first-names>T</api:first-names><api:separate-first-names><api:first-name>T</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Moore</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000083355400003&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.7164/antibiotics.52.862</api:text><api:links><api:link type="doi" href="http://doi.org/10.7164/antibiotics.52.862"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.7164/antibiotics.52.862"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">249WC</api:identifier><api:identifier scheme="pubmed">10604755</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0021-8820</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965812"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>10</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>JOURNAL OF ANTIBIOTICS</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>862</api:begin-page><api:end-page>872</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>A novel (6&lt;i&gt;S&lt;/i&gt;)-4,6-dimethyldodeca-2&lt;i&gt;E&lt;/i&gt;,4&lt;i&gt;E&lt;/i&gt;-dienoyl ester of phomalactone and related α-pyrone esters from a &lt;i&gt;Phomopsis&lt;/i&gt; sp with cytokine production inhibitory activity</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>52</api:text></api:field></api:native></api:record><api:record format="native" id="23615" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000083355400003" last-modified-when="2014-07-25T11:04:52.353+01:00"><api:citation-count>7</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Wrigley</api:last-name><api:initials>SK</api:initials><api:first-names>SK</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>K</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Sadeghi</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Bahl</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Whiting</api:last-name><api:initials>AJ</api:initials><api:first-names>AJ</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Ainsworth</api:last-name><api:initials>AM</api:initials><api:first-names>AM</api:first-names><api:separate-first-names><api:first-name>A</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Martin</api:last-name><api:initials>SM</api:initials><api:first-names>SM</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Katzer</api:last-name><api:initials>W</api:initials><api:first-names>W</api:first-names><api:separate-first-names><api:first-name>W</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Ford</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kau</api:last-name><api:initials>DA</api:initials><api:first-names>DA</api:first-names><api:separate-first-names><api:first-name>D</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Robinson</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Hayes</api:last-name><api:initials>MA</api:initials><api:first-names>MA</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Elcock</api:last-name><api:initials>C</api:initials><api:first-names>C</api:first-names><api:separate-first-names><api:first-name>C</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Mander</api:last-name><api:initials>T</api:initials><api:first-names>T</api:first-names><api:separate-first-names><api:first-name>T</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Moore</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0021-8820</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965812"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>10</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>J ANTIBIOT</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>CYTOPLASMIC GROUND SUBSTANCE</api:keyword><api:keyword>PSEUDOARACHNIOTUS-ROSEUS</api:keyword><api:keyword>STRUCTURE ELUCIDATION</api:keyword><api:keyword>HUMAN-MONOCYTES</api:keyword><api:keyword>ENZYME ICE</api:keyword><api:keyword>INTERLEUKIN-1</api:keyword><api:keyword>ARANOROSIN</api:keyword><api:keyword>MEMBRANES</api:keyword><api:keyword>RELEASE</api:keyword><api:keyword>CELLS</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>862</api:begin-page><api:end-page>872</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>10</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>A novel (6S)-4,6-dimethyldodeca-2E,4E-dienoyl ester of phomalactone and related alpha-pyrone esters from a Phomopsis sp with cytokine production inhibitory activity</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>52</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword scheme="mesh" origin="record-data" source="pubmed">Dose-Response Relationship, Drug</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Esters</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Fermentation</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Interleukin-1</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Lactones</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Lipopolysaccharides</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Molecular Structure</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Pyrones</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Structure-Activity Relationship</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Tumor Necrosis Factor-alpha</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">U937 Cells</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">U937 Cells</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Esters</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Lactones</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Pyrones</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Lipopolysaccharides</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Tumor Necrosis Factor-alpha</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Interleukin-1</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Fermentation</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Molecular Structure</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Structure-Activity Relationship</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Dose-Response Relationship, Drug</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3101 Biochemistry and Cell Biology</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">31 Biological Sciences</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Dose-Response Relationship, Drug</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Esters</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Fermentation</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Interleukin-1</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Lactones</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Lipopolysaccharides</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Molecular Structure</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Pyrones</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Structure-Activity Relationship</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Tumor Necrosis Factor-alpha</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">U937 Cells</api:keyword><api:keyword origin="record-data" source="wos">CYTOPLASMIC GROUND SUBSTANCE</api:keyword><api:keyword origin="record-data" source="wos">PSEUDOARACHNIOTUS-ROSEUS</api:keyword><api:keyword origin="record-data" source="wos">STRUCTURE ELUCIDATION</api:keyword><api:keyword origin="record-data" source="wos">HUMAN-MONOCYTES</api:keyword><api:keyword origin="record-data" source="wos">ENZYME ICE</api:keyword><api:keyword origin="record-data" source="wos">INTERLEUKIN-1</api:keyword><api:keyword origin="record-data" source="wos">ARANOROSIN</api:keyword><api:keyword origin="record-data" source="wos">MEMBRANES</api:keyword><api:keyword origin="record-data" source="wos">RELEASE</api:keyword><api:keyword origin="record-data" source="wos">CELLS</api:keyword><api:keyword scheme="for" origin="issn-inferred">0605 Microbiology</api:keyword><api:keyword scheme="for" origin="issn-inferred">1115 Pharmacology and Pharmaceutical Sciences</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Medicinal &amp; Biomolecular Chemistry</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Microbiology</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3107 Microbiology</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3214 Pharmacology and pharmaceutical sciences</api:keyword></api:keywords></api:all-labels><api:journal issn="0021-8820" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/965812" title="Journal of Antibiotics"><api:records><api:record source-name="summary"><api:title>Journal of Antibiotics</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/672/relationships"/></api:object></api:result></api:response>